SYMYX TECHNOLOGIES INC
10-Q, EX-27.01, 2000-08-08
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SYMYX TECHNOLOGIES INC, 10-Q, 2000-08-08
Next: MENTOR ON CALL INC, 10QSB, 2000-08-08



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED
BALANCE SHEETS, CONDENSED STATEMENTS OF OPERATIONS AND NOTES TO CONDENSED
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               JUN-30-2000             JUN-30-1999
<CASH>                                          45,081                  10,699
<SECURITIES>                                         0                   6,753
<RECEIVABLES>                                      705                     809
<ALLOWANCES>                                         0                       0
<INVENTORY>                                        611                      30
<CURRENT-ASSETS>                                49,248                  19,493
<PP&E>                                          36,278                  21,617
<DEPRECIATION>                                  10,185                   5,185
<TOTAL-ASSETS>                                 143,031                  61,191
<CURRENT-LIABILITIES>                           15,441                  14,221
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                            30                       8
<OTHER-SE>                                     122,827                  39,144
<TOTAL-LIABILITY-AND-EQUITY>                   143,031                  61,191
<SALES>                                          5,525                       0
<TOTAL-REVENUES>                                23,098                  15,630
<CGS>                                            1,729                       0
<TOTAL-COSTS>                                    1,729                       0
<OTHER-EXPENSES>                                23,697                  14,970
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 506                     549
<INCOME-PRETAX>                                    699                   1,073
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                699                   1,073
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                       699                   1,073
<EPS-BASIC>                                     0.02                    0.21
<EPS-DILUTED>                                     0.02                    0.16


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission